- Home
- AFCG vs INMB Comparison
AFCG vs INMB Comparison
Compare AFCG & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFCG | INMB |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 64.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AFCG | INMB |
|---|---|---|
| Price | $3.57 | $2.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $4.50 | ★ $5.40 |
| AVG Volume (30 Days) | 104.9K | ★ 339.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $24,563,601.00 | $50,000.00 |
| Revenue This Year | $1,334.03 | N/A |
| Revenue Next Year | $17.33 | N/A |
| P/E Ratio | $4.97 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $2.06 | $1.09 |
| 52 Week High | $4.69 | $2.50 |
Technical Indicators
Market Signals| Indicator | AFCG | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 58.65 |
| Support Level | $2.75 | $1.16 |
| Resistance Level | $3.84 | $2.50 |
| Average True Range (ATR) | 0.18 | 0.12 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 78.00 | 52.51 |
Price Performance
Historical ComparisonAbout AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.